Publication | Closed Access
Phase I Study of Lee011 (Cdk4/6 Inhibitor) in Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Cyclin D–Cdk4/6 Pathway-Activated Tumors
11
Citations
0
References
2014
Year
OncologyMalignant Rhabdoid TumorsMalignant DiseaseMedicineCancer Cell BiologyPathologyCdk4/6 InhibitorAnti-cancer AgentCancer TreatmentCancer BiologyCell BiologyCancer ResearchTumor Biology
No additional data available for this publication yet. Check back later!